Pune-based Serum Institute of India (SII) and France-based Valneva SE announced on Thursday that SII has signed an agreement to manufacture the latter's anti-chikungunya vaccine for...
R21 is the second malaria vaccine available in sub-Saharan Africa, following the widespread introduction of RTS, S and malaria vaccines | Photo: Bloomberg 4 min read...
The Serum Institute of India (SII) has started shipping the first batch of R21/Matrix-M malaria vaccine to Africa. The first shipment is destined for the Central...
The company's plan to expand its vaccine production capacity from 2 million to 3 million doses is now in line with the HPV vaccine against cervical...
From newer therapies for Alzheimer’s disease to developing off-the-shelf gene therapies for cancer, 2024 holds out hope for exciting developments in medicine that can transform our...
More than 600,000 new cases of cervical cancer and more than 3,40,000 deaths from the disease were reported worldwide in 2020, according to an observational study...
Recent Comments